More and more news came to light this week, according to which a coronavirus vaccine developed and manufactured in Hungary is expected to be completed by 2022. According to some news, the Hungarian government would base the vaccination strategy from 2022 on this Hungarian vaccine.
László György, State Secretary of the Ministry of Innovation and Technology, announced at a press conference of the operational board that the foundations of the national vaccine factory will be laid in Debrecen. Debrecen was chosen because, according to the plans, the knowledge of the University of Debrecen will greatly help the work of the factory, and the joint work of the factory and the university can be successful in the long run, writes portfolio.hu.
The goal is to produce a Hungarian vaccine in Hungary by the end of 2022.
In addition, the Hungarian government plans to make the country independent from other countries and to provide self-sufficiency against epidemics and catching diseases. According to the article of index.hu, one of the long-term goals is that the factory will serve the entire Carpathian Basin in addition to Hungary.
The news of the construction of the factory is related to the fact that on Thursday, the Government Info revealed that Hungary opts out from the next stage of the European Union vaccine procurement. With this, Hungary is the only EU member state that did not take advantage of this opportunity. According to calculations, from the second half of 2022, Hungary will be able to produce the right amount of COVID-19 vaccines at the factory in Debrecen.
“The Hungarian vaccine that is being prepared will be very similar to Sinopharm,”
said István György, the head of the vaccination working group. Cecília Müller also said earlier that the Hungarian coronavirus vaccine will be similar to the flu virus and tick encephalitis vaccine. This means that it will contain an inactivated virus, just as the Chinese Sinopharm vaccine was made. The advantage of the Hungarian vaccine may be that the virus strains in the vaccine and those causing the diseases are as similar as possible. After all, the type occurring and circulating in Hungary was isolated for the production of the vaccine. This will hopefully provide more effective protection against viruses, for example, the coronavirus.